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Abstract
The inflammatory response is driven by signals that recruit and elicit immune cells to areas of tissue damage or infection.
The concept of a mononuclear phagocyte system postulates that monocytes circulating in the bloodstream are recruited to
inflamed tissues where they give rise to macrophages. A recent publication demonstrated that the large increase in the
macrophages observed during infection was the result of the multiplication of these cells rather than the recruitment of
blood monocytes. We demonstrated previously that B-1 cells undergo differentiation to acquire a mononuclear phagocyte
phenotype in vitro (B-1CDP), and we propose that B-1 cells could be an alternative origin for peritoneal macrophages. A
number of recent studies that describe the phagocytic and microbicidal activity of B-1 cells in vitro and in vivo support this
hypothesis. Based on these findings, we further investigated the differentiation of B-1 cells into phagocytes in vivo in
response to LPS-induced inflammation. Therefore, we investigated the role of B-1 cells in the composition of the peritoneal
macrophage population after LPS stimulation using osteopetrotic mice, BALB/Xid mice and the depletion of monocytes/
macrophages by clodronate treatment. We show that peritoneal macrophages appear in op/op(2/2) mice after LPS
stimulation and exhibit the same Ig gene rearrangement (VH11) that is often found in B-1 cells. These results strongly
suggest that op/op(2/2) peritoneal ‘‘macrophages’’ are B-1CDP. Similarly, the LPS-induced increase in the macrophage
population was observed even following monocyte/macrophage depletion by clodronate. After monocyte/macrophage
depletion by clodronate, LPS-elicited macrophages were observed in BALB/Xid mice only following the transfer of B-1 cells.
Based on these data, we confirmed that B-1 cell differentiation into phagocytes also occurs in vivo. In conclusion, the results
strongly suggest that B-1 cell derived phagocytes are a component of the LPS-elicited peritoneal macrophage population.
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Introduction
van Furth and colleagues introduced the concept of a
mononuclear phagocyte system (MPS) suggesting that all macro-
phages, including those appearing in inflammatory foci and
residing in tissues under normal steady-state conditions, are
derived from monocytes, which differentiate via promonocytes
from monoblasts in the bone marrow [1]. Under stimulated
conditions, monocytes adhere to activated vascular endothelial
cells, migrate into tissues and differentiate into macrophages [2].
The development of monocytic cells and their differentiation into
macrophages are supported by macrophage colony-stimulating
factor (M-CSF) [3].
Osteopetrotic mice (op/op(2/2) mice) contain a mutation in the
coding region of the cfms gene, which results in a deficiency of M-
CSF [3]. This mutation causes a defect that is associated with
osteoclastogenesis and hematopoiesis including a near complete
deficiency of monocyte production and a complete deficiency of
monocyte-derived macrophages. The daily administration of M-
CSF to op/op(2/2) mice increases the number of peripheral blood
monocytes, and the differentiation and maturation of monocyte-
derived macrophages and osteoclasts is increased to a level found
in the normal littermates [4].
Curiously, tissue macrophages develop in various organs and
tissues of op/op(2/2) mice [3]. These small, round, and immature
cells exhibit an ultrastructure that is characterized by the poor
development of intracellular organelles, particularly lysosomal
granules. These immature macrophages are present in various
organs and tissues of op/op(2/2) mice, particularly in the lungs,
spleen and brain. Because op/op(2/2) mice lack functional M-
CSF activity and monocytic cells in their peripheral blood,
immature macrophages are called ‘‘M-CSF-independent macro-
phages’’ and are considered to be derived from an earlier
macrophage precursor cell than the monocyte [3,4,5]. In op/
op(2/2) mice, despite the absence of blood monocytes, immature
macrophages differentiate from early hematopoietic progenitors
without the activity of M-CSF in various organs and tissues [4].
Although various transcription factors are involved in the
development and differentiation of hematopoietic stem cells into
tissue macrophages, the PU.1 hematopoietic transcription factor is
required for the differentiation of early hematopoietic precursors
into macrophages and B cells. PU.1-deficient mice die in the fetal
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stages of development, or they die from septicemia within two days
after birth [6,7]. In these mutant fetuses or neonatal mice,
monocyte-derived macrophages are completely absent [6,7].
Hematopoietic precursors of PU.1-deficient mice did not respond
to M-CSF or granulocyte macrophage colony-stimulating factor
(GM-CSF) [8]. However, when the mutant mice are rescued by
treatment with antibiotics immediately after birth and survive for
two weeks, a small number of macrophages develop in various
tissues, such as the liver and bone marrow [6]. This result suggests
that tissue macrophages develop from early hematopoietic
progenitor cells in PU.1- deficient mice and that the development
and differentiation of early progenitors into tissue macrophage
occurs not only in early ontogeny but also in postnatal life.
Previous studies revealed that pre-B cell lines established in a
long-term bone marrow culture differentiate into CD5-positive
macrophages in vitro [9,10]. In addition, Takahashi et al. [10]
demonstrated that the intravenous treatment of BALB/c and C3H
mice with GM-CSF increases the number of CD5-positive
macrophages in the peritoneal cavities. These cells were also
found in motheaten mutant mice (mev/mev) but were absent in
nude, severe combined immunodeficient (scid), X-linked immuno-
deficient (xid) and alymphoplasia mice (aly/aly) [11]. The mev/mev
mice exhibit a tyrosine phosphatase deficiency in their hemato-
poietic cells, which results in the impairment of T and B cells, but
they exhibit an increased number of B-1 cells [11]. After daily
intravenous injection with GM-CSF for five days, many CD5+
macrophages appeared in the peritoneal cavity and in omental
milky spots of normal mice; however, fewer macrophages were
detected in op/op(2/2)mice [10]. These results indicate that GM-
CSF, in combination with M-CSF, induces the development and
differentiation of CD5+ macrophages in the peritoneal cavity,
particularly in the omental milky spots. In the peritoneal cavity of
GM-CSF-treated mice, the percentage of hematopoietic progen-
itor cells doubly positive for CD5 and CD34 or c-kit and
macrophage precursor cells doubly positive for CD5 and ER-
MP58 or ER-MP20 increased significantly during the develop-
ment of CD5+ macrophages and CD5 B cells, suggesting that
CD5+ macrophages and B cells may share a bipotential progenitor
in vivo [10].
Previously, we demonstrated that B-1b cells differentiate to
acquire a mononuclear phagocyte phenotype following attach-
ment to a substrate in vitro [12]. B-1b cells spontaneously express
both myeloid- and lymphoid-restricted transcription factors. When
the cells are induced to differentiate into phagocytes, the lymphoid
genes encoding E box protein (E2A), early B-cell factor (EBF), and
paired box 5 (Pax5) are down-modulated, whereas the expression
of genes related to myeloid commitment are sustained. Further-
more, B-1b cell-derived phagocytes (B-1CDPs) decrease immuno-
globulin M (IgM) expression but retain the expression of the heavy
chain gene variable VH11 or VH12, an immunoglobulin gene
rearrangement predominantly expressed by B-1 cells [13]. The
maintenance of lymphoid characteristics in B-1CDPs is charac-
teristic of a unique type of phagocyte that is not related to
monocyte-derived macrophages. Recent studies have shown that
these cells take up apoptotic thymocytes and bacteria in vitro and in
vivo [14,15]. In addition, Mussalem et al (in press) demonstrated that
Propionibacterium acnes treatment induced the commitment of B-1
cells to the myeloid lineage and their differentiation into
phagocytes.
In this study, we demonstrate that ‘‘M-CSF-independent
macrophages’’ from op/op(2/2) mice are B-1CDPs. We also
demonstrated that B-1CDPs are a source of macrophages after
LPS stimulation not only in op/op(2/2) mice but also in normal
mice. Additionally, the transfer of B-1 cells to Balb/Xid mice
confirms that this inflammatory stimulus induces the proliferation
of peritoneal resident macrophages, even though these proliferat-
ing macrophages are derived from B-1 cells.
Materials and Methods
Animals
Breeding pairs of heterozygous B6C3-CSF-1op/+ mice were
obtained from the Jackson Laboratory (Bar Harbor, ME, USA)
and were bred at the animal facilities at Sir William Dunn School
of Pathology, University of Oxford. The mutant op/op offspring
were clearly identifiable at 10 days of age by the failure of the
incisor teeth to erupt and by their domed skull. Toothless mice
were separated from their normal siblings at weaning and were fed
with powdered mouse food. Homozygous mutant (op/op2/2) and
heterozygous (op/op+/?) littermates were used at 6–8 weeks of age.
C57BL6, BALB/c, and BALB/Xid male mice (6–8 weeks old)
were bred locally at Universidade Federal de Sa˜o Paulo under
standard pathogen-free conditions.
Ethics Statement
All experiments were conducted with the approval of the
institutional animal care and use committee. The Comiteˆ de E´tica
em Pesquisa (CEP) da Universidade Federal de Sa˜o Paulo/
Hospital Sa˜o Paulo (ID number: CEP 1015/2005) approved this
study.
In vivo LPS injection
Mice were inoculated intraperitoneally (i.p.) with 10 mg of
lipopolysaccharide (LPS - Escherichia coli serotype O26:B6, 90–99%
pure; Sigma–Aldrich, St. Louis, MO, USA) in 200 mL of
phosphate buffered saline (PBS) solution or with PBS alone and
were killed 3 days later for flow cytometric analysis of the
peritoneal macrophages. In some experiments, carboxyfluorescein
succinimidyl ester (CFSE) was injected simultaneously with LPS
and control PBS for the analysis of monocyte migration or in vivo
proliferation.
Peritoneal cells
Peritoneal cells were collected from the abdominal cavity of
mice by repeated lavage with 2 ml of RPMI-1640 medium (Sigma,
St Louis, MO). Cell viability was evaluated using the trypan blue
dye exclusion method. The absolute cell numbers were deter-
mined, and the cells were submitted to flow cytometry analysis, cell
purification and DNA extraction.
Flow Cytometry Analysis
The peritoneal cells were stained with monoclonal antibodies
and were analyzed as described below. The cell suspensions were
pre-incubated with anti–CD16/CD32 mAb to block FccRII/III
receptors and stained on ice for 15 minutes with the following
fluorochrome conjugated mAbs: fluorescein isothiocyanate
(FITC)- or peridinin clorophyll cyanine dye 5 (PerC-Cy5)-labeled
anti-mouse CD19, phycoerythrin (PE)-labeled anti-mouse CD23,
peridinin clorophyll protein (PerCP)-labeled anti-mouse CD5,
allophycocyanin (APC) or Pacific blue-labeled anti-mouse CD11b,
PE- or FITC-labeled IgM and Pacific orange-labeled F4/80.
Antibodies were purchased from BD Bioscience, with the
exception of the Pacific blue-labeled anti-mouse CD11b and the
Pacific orange-labeled F4/80, which were from Invitrogen. Cell
staining was performed in accordance with the manufacturer’s
protocol, and the combinations of different antibodies used are
indicated in each figure. Flow cytometric detection was performed
on FACS Canto, FACS Calibur (Becton Dickinson) or AttuneH
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Acoustic Focusing Flow Cytometer (Life Technology, Applied
Biosystems) instruments, and analysis was performed using Flow Jo
software (Tree Star). Fluorescence-minus-one (FMO) controls
were used to distinguish positively stained from autofluorescent
cells.
Peritoneal Macrophage Purification
Non-B cells were separated from peritoneal cells using the
MiniMACS magnetic bead system (Miltenyi Biotech, Bergisch
Gladbach, Germany). Approximately 107 peritoneal cells were
incubated with monoclonal FITC anti-mouse CD19 and FITC
anti-IgM (Pharmingen, San Diego, CA) diluted in a saline solution
containing 5% bovine serum albumin (BSA) and 2 mM
ethylenediaminetetra-acetic acid (EDTA). After washing with the
same dilution buffer, anti-rat immunoglobulin G (IgG) coupled to
iron (Fe) (Miltenyi Biotec) was added to the cell suspension for
45 min at 4uC. The cells were passed through a 25 MS positive
selection column (Miltenyi Biotec) to capture the B cells. Non-B
cells were collected and after cell separation; the cells were stained
on ice for 15 minutes with APC-labeled anti-mouse CD11b, PE-
streptavidin and biotin anti-F4/80 and were submitted to FACS
analysis. Non-B cell exclusion was confirmed by flow cytometry
analysis and after confirming the absence of CD19+IgM+ cells, the
non-B cells were submitted to Ig gene rearrangement experiments.
B-1 cell sorting and adoptive transfer to BALB/Xid mice
Peritoneal B-1 cells were purified from peritoneal lavages
pooled from 10 mice, and the cells were sorted using a FACSAria
III Cell Sorter (BD Biosciences) using the parameters described in
Figure S1. Briefly, doublets were excluded from total peritoneal
cells by the analysis of FSC-A6FSC-H parameters. Only single
cells were considered to delimit the lymphocyte gate.
CD19+CD232 cells (B-1 cells) were sorted according to the
expression of CD19 and CD23 on lymphocytes. After cell-sorting,
purified B-1 cells were stained with CFSE before transfer to
BALB/Xid mice. Next, 16106 cells were transferred to the
peritoneal cavity of BALB/Xid mice simultaneously with the
injection of LPS. After 3 days, the peritoneal cells were collected
for analysis. In some experiments, clodronate treatment was
performed before the transfer of the B-1 cells.
Ig gene rearrangement analysis
Non-B cells obtained as described above were submitted to
DNA extraction. DNA amplification was performed using a
Superscript Cells Direct cDNA Synthesis System (Invitrogen). The
PCR products were selected for VH11 and VH12 as described by
Popi et al. [13]. The cDNAs were selected based on the expression
of housekeeping genes. B cells were used as the positive control.
CFSE staining
The B-1 cells were stained with CFSE prior to their transfer.
Briefly, purified B-1 cells (16106 cells/ml) were incubated with
50 mM CFSE (Molecular Probes) in prewarmed PBS for 5 min at
37uC and washed twice with RPMI medium supplemented with
10% fetal bovine serum. In other experiments, CFSE (25 mM) was
injected directly into the peritoneal cavity of mice to stain the
resident peritoneal cells. To confirm that only peritoneal cells were
stained by CFSE, after 1 hour, the blood and spleen cells were
analyzed, and no staining was observed in these samples.
Liposome preparation
Clodronate was entrapped in liposomes by ether injection as
described by Lepique et al [16]. Depletion of macrophages was
performed before the LPS stimulation. The mice were i.p injected
twice with 200 mL of the liposome preparation (12 mg of
clodronate) at 72 and 24 h before LPS injection. In some
experiments, the B-1 cell transfer was performed simultaneously
with the injection of LPS.
Statistical analysis
All data shown are the means (SEM). Significant differences
between sample means were determined using the Student’s t test
or two-way ANOVA.
Results
Macrophages and B-1 cells are reduced in peritoneal
cavity of op/op(2/2) mice
It has been reported that the number of hematopoietic cells in
op/op(2/2) mice is lower than in op/op(+/?) or wild type mice
[17,18]. Cells were collected from the peritoneal cavity of both op/
op(2/2) mice and their normal littermates (op/op(+/?)). As shown in
Figure 1A, the total number of peritoneal cells in the op/op(2/2)
mice was lower when compared with op/op(+/?) mice. The cell
populations from the peritoneal cavity of op/op(2/2) and op/op(+/?)
mice were analyzed based on surfacemarker expression. Quantitative
and qualitative analysis was performed to characterize B cells (IgMlow
CD23+CD19+CD11b2CD52), macrophages (IgM2CD11b+F4/
80+CD192CD52) and B-1 cells (IgMhighCD232CD19+CD11b+
CD5+/2). Confirming data previously described in the literature
[17], the number of macrophages in the op/op(2/2) mice was
drastically reduced (Figure 1B and C). Analysis of the B cell subsets
revealed a small reduction in the B-1 cell population (not significant),
and no differences in B cell numbers were detected when op/op(2/2)
mice and their littermates were compared (Figure 1B and C).
LPS increases the number of B-1 cells and macrophages
in the peritoneal cavity of op/op(2/2) mice
M-CSF-derived macrophages from bone marrow progenitors
generate large amounts of TNF-a after stimulation with LPS [19].
After LPS stimulation, the phagocytic rate in peritoneal macro-
phages isolated from the op/op(2/2) mice was significantly
reduced compared with the macrophages isolated from the wild
type mice [20]. These observations support the hypothesis that the
functional heterogeneity of peritoneal macrophages exists between
op/op+/+ mice and op/op2/2 mice [20]. Next, we investigated B-
1 cells (IgMhighCD232CD19+CD11b+CD5+/2) and macrophages
(IgM2CD11b+F4/80+CD192CD52) in the peritoneal cavity of
op/op(2/2) mice after LPS stimulus in vivo. Following LPS
stimulation, a significant increase in the total number of peritoneal
cells was observed (Figure 2A). Analysis of the different peritoneal
cell subtypes revealed a larger increase in the B-1 cell population
from op/op(2/2) mice after LPS treatment compared with the
increase observed in op/op(+/?) mice. As expected, the number of
macrophages in the op/op(+/?) mice increased following the
inflammatory stimulus. Intriguingly, the LPS stimulus also induced
an increase in the ‘‘macrophage’’ population in op/op(2/2) mice,
even though these animals have a severe deficiency of monocyte-
derived macrophages. It is important to emphasize that in this
study, the macrophages were characterized based on surface
marker expression, which means that these cells were CD11b and
F4/80(low or high) double positive cells, concomitant with the
absence of CD19, IgM and CD5. Based on the upsurge in the
macrophage population in the op/op(2/2) mice, we questioned
the origin of these phagocytes. We have demonstrated previously
that B-1 cells differentiate into phagocytes (B-1CDP) in vitro
[12,13]. After differentiation, B-1CDPs lose their B cell marker
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expression and express monocyte-derived macrophages surface
markers. Therefore, we hypothesized that the inflammatory
stimulus induced B-1 cell differentiation into phagocytes in vivo
and that the enlargement of the macrophage population may be
related to the emergence of B-1CDPs.
‘‘Macrophages’’ from op/op(2/2) mice contain an Ig gene
rearrangement
Considering that in op/op(2/2) mice monocyte-derived mac-
rophages are virtually absent, and LPS increased the number of
cells characterized as ‘‘macrophages’’, we investigated if these cells
were B-1 cell-derived phagocytes. Because B-1CDPs contain the
VH11 Ig gene rearrangement [13], we investigated the probable
expression of this Ig gene rearrangement in macrophages from the
peritoneal cavity of op/op(2/2) mice. Peritoneal cells were
collected from the peritoneal cavity of mice following administra-
tion of the LPS stimulus, and B cells (CD19+IgM+) were separated
from the non-B cells (CD192IgM2) using microbeads (Figure 3A).
The non-B cells were collected and were submitted to cytometric
analysis. The results showed that the peritoneal non-B cells were
IgM2CD192CD11b+F4/80+ (99,98%), and they were character-
ized as ‘‘macrophages’’ (Figure 3A). Using methods described in
the literature [13], the Ig gene rearrangement in ‘‘macrophages’’
and B cells was analyzed. The VH11 Ig gene rearrangement was
not found in macrophages from op/op(+/?) mice, which supports
the current concept that the majority of these cells result from
monocyte differentiation. However, analysis of the Ig gene
rearrangement in ‘‘macrophages’’ from op/op(2/2) mice clearly
demonstrates that these cells contain the VH11 Ig gene
rearrangement that is found in B-1 cells (Figure 3B). These results
strongly suggest that B-1 cell-derived phagocytes (B-1CDPs) are a
component of ‘‘MCSF independent macrophages’’ in the
peritoneal cavity after LPS stimulation.
The increase in macrophages following LPS stimulation
occurs independently of monocytes
Although these data reinforce the hypothesis that B-1 cells
differentiate into phagocytes in vivo, there is a possibility that the
large increase in macrophages observed after the LPS stimulus
results from the expansion of the peritoneal resident population
rather than from monocyte recruitment.
To determine the role of monocytes in macrophage accumu-
lation, we injected clodronate-loaded liposomes intraperitoneally
(i.p.). Clodronate treatment depletes monocytes and blocks tissue
infiltration by macrophages in a variety of inflammatory settings
[21,22,23]. First, we confirmed that the clodronate treatment
protocol adopted in this study resulted in an effective and sustained
depletion of peritoneal macrophages. As expected, clodronate-
Figure 1. Characterization of peritoneal cell subpopulations in the peritoneal cavity of op/op(2/2) mice. (A) The number of cells in the
peritoneal cavity of op/op(2/2) mice is significantly reduced when compared to the littermates. Peritoneal cells were collected from op/op(2/2) mice
and their normal littermates (op/op(+/?)), and the cells were counted (p,0.01). (B) Percentage of B-1 cells, B-2 cells and macrophages in the peritoneal
cavity of op/op(2/2) mice and littermates (op/op(+/?)). (C) Absolute number of B-1 cells (ns), B-2 cells (ns) and macrophages (MQ - p,0.0001). Cell
populations were determined by flow analysis based on the following surface marker expression: B-1 cells (CD232CD19+CD11b+), MQ (CD11b+F4/
80+CD192), and B-2 (CD23+CD19+CD11b2). Graphs are representative of two independent experiments using 6 mice per group per experiment.
doi:10.1371/journal.pone.0034570.g001
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treated mice remained depleted of peritoneal macrophages for at
least 5 days after the last clodronate-liposomes injection
(Figure 4A). Considering this depletion, 24 hours after the last
clodronate-liposomes injection, BALB/c mice were injected with
LPS. To discriminate resident peritoneal cells from newly
migrating cells, CFSE was injected into the peritoneal cavity prior
to LPS injection. Thus, the resident cells were now CFSE+ cells.
After 3 days, the peritoneal macrophage population was analyzed.
First, peritoneal B cells were excluded based on their CD19
expression. Subsequently, macrophages were identified by their
expression of CD11b and F4/80. As expected, this cell population
increased after LPS stimulation in the non-clodronate treated mice
(control group). Interestingly, the LPS stimulus induced an
increase in the macrophage population, even though monocyte/
macrophage depletion was induced by clodronate (Figure 4B).
These data corroborate the increase in the macrophage popula-
tion after LPS stimulation in op/op(2/2) mice.
We also analyzed the percentage of macrophages (CD11b+F4/
80+ cells) staining with CFSE, which were considered resident
macrophages (Figure 4C). We observed that 96% of the
macrophages were CFSE+ in the clodronate-treated mice
compared to 64.4% in the non-treated mice (control group). This
data confirms that clodronate treatment causes macrophage
depletion and the inhibition of monocyte migration to the
peritoneal cavity. Furthermore, after stimulation with LPS, only
32% of the peritoneal macrophages were CFSE+, whereas in the
clodronate treated group, this percentage increased to 98%. These
data confirm that monocyte-derived macrophages were eliminated
by clodronate treatment (Figure 4C). Furthermore, compared with
the control group, we observed a smaller percentage of CFSE+
macrophages in the peritoneal cavity of LPS-stimulated mice
indicating that the LPS stimulus induced monocyte migration and
differentiation. However, when the monocyte-macrophage popu-
lation was depleted, an increase in the number of peritoneal
resident cells was observed following LPS stimulation. Based on
this observation, we concluded that the enlargement of the
macrophage population after LPS stimulation occurs not only as
consequence of monocyte migration but also as result of an
increase in one of the resident cell populations in the peritoneal
cavity.
Given that CD11b+F4/80+CFSE+ cells are resident peritoneal
macrophages, macrophage proliferation was determined based on
CFSE decay. Therefore, CD11b+F4/80+CFSE+ cells were divided
into non-proliferating cells (CFSEhigh, CFSE+ macrophages) and
proliferating macrophages (CFSEdim). Undoubtedly, the LPS
stimulus induced the proliferation of resident macrophages; 52%
of the resident macrophages exhibited diminished CFSE fluores-
cence in the LPS-treated group. More importantly, after
peritoneal macrophage depletion by clodronate treatment, a
pronounced proliferation of CD11b+F4/80+ cells was still
observed (80% of resident macrophages were proliferating in the
clodronate+LPS-treated group) (Figure 4D and E). These data
reinforce the theory that the LPS stimulus provoked an increase in
the macrophage population, at least partially, by inducing the
proliferation of a peritoneal resident cell subtype. Furthermore,
this increase was observed despite the depletion of the monocyte-
derived macrophage population. It is reasonable to assume that
other peritoneal resident cells are induced by LPS to differentiate
into ‘‘macrophages’’ and are responsible for the increase in this
population. These data corroborate our hypothesis that LPS
stimulates the differentiation of B-1 cells into phagocytes in vivo. It
is important to note that B-1 cells are not affected by clodronate
treatment (Figure 4F).
B-1CDPs are part of the LPS-elicited peritoneal
macrophage population
To confirm the hypothesis that after LPS stimulation, the
macrophage population is composed of B-1 cell-derived phago-
cytes, the peritoneal cell population of BALB/Xid mice was
analyzed. To evaluate the participation of B-1 cells in the
composition of the macrophage population, B-1 cells were
purified, stained with CFSE and transferred to the peritoneal
cavity of BALB/Xid mice prior to administration of the LPS
stimulus. Figure 5A illustrate the acquisition of purified B-1 cells,
corresponding to 98,3% CD19+CD232 cells sorted. After CFSE
staining, B-1 cells (CD19+CD232CFSE+ cells) were transferred
intraperitoneally (i.p.) to BALB/Xid mice simultaneously with the
LPS injection. After 3 days, the peritoneal cells from these mice
were analyzed. Only 3.4361.23% of the lymphocytes present in
Figure 2. LPS increases the number of B-1 cells and macro-
phages in the peritoneal cavity of op/op(2/2) mice. (A) Number of
peritoneal cells collected and counted individually from 6 mice (op/
op(2/2)) and their littermates (op/op(+/?)) in control or LPS-treated
groups. (B) Absolute number of B-1 cells and macrophages in untreated
control (%) or LPS stimulated (&) littermates op/op(+/?) and op/op(2/2)
mice. Cell populations were determined by flow analysis based on
surface marker expression: B-1 cells (CD232CD19+CD11b+) and MQ
(CD11b+F4/80+CD192). Flow cytometric analysis showed significantly
increased percentages of B-1 cells in both mice lineages after LPS
stimulation when compared to untreated mice. LPS also increased the
number of macrophage cells in both groups of mice. Significant
differences between the sample means are indicated as follows:
**p,0.05, ***p,0.01, and ****p,0.001. The results are representative
of two independent experiments.
doi:10.1371/journal.pone.0034570.g002
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Figure 3. Elicited peritoneal ‘‘macrophages’’ from op/op(2/2) mice exhibit Ig gene rearrangements. A) Flow cytometry analysis of total
peritoneal cells to distinguish B cells (CD19+) and non-B cells (CD192). After cell purification, the CD19+ cells and the CD192 cells were collected
separately. The right dot plots show that non-B cells are F4/80+CD11b+ and are thus characterized as macrophages. B) Analysis of heavy chain
variable gene VH11 expression by peritoneal B cells and macrophages from unstimulated or LPS-stimulated op/op(+/?) and op/op(2/2) mice. The PCR
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the peritoneal cavity of BALB/Xid mice were B-1 cells, which was
equivalent to 0.27% of the total number of cells. After transfer of
the B-1 cells, this percentage increased to 31.662.8% of the
peritoneal lymphocytes (5.12% of the total cells) (Figure 5B). The
increase in the B-1 cell population after cell transfer to BALB/Xid
mice is demonstrated in Figure 5C.
The macrophage population was also analyzed after B-1 cell
transfer to BALB/Xid mice. Using this strategy, we analyzed the
participation of B-1 cell-derived phagocytes in the composition of
the macrophage population. The CD11b+F4/80+ cells were
selected, and the number of CFSE+ cells (B-1 cells) in this
population was determined (Figure 5D). After transfer of the B-1
CFSE+ cells to BALB/Xid mice, we determined that at least 15%
of the macrophages were derived from B-1 cells (CFSE+). No
difference was observed in the absolute number of macrophages
when BALB/Xid and BALB/Xid+B-1 were compared. However,
after LPS stimulation, a subtle increase (16.66%) in the
macrophage population of BALB/Xid+B-1 mice was observed
when compared to non-stimulated BALB/Xid mice (Figure 5E).
The data shown here confirm that B-1 cells differentiate into
phagocytes in vivo, and support the hypothesis that B-1CDP is a
component of the macrophage population after LPS stimulation in
the peritoneum.
To demonstrate definitively that B-1CDPs contribute to
increasing peritoneal macrophages after LPS stimulation,
BALB/Xid mice were treated with clodronate as described above.
At 24 hours following the last clodronate injection, purified B-1
CFSE+ cells were transferred to the peritoneal cavity and the LPS
was injected. As shown in Figure 6A, the B-1 cell population was
present in BALB/Xid mice after transfer. Once again, it is
important to note that clodronate treatment did not affect the B-1
cells, despite the efficiency of clodronate treatment, which was
confirmed by complete deletion of the macrophage population in
BALB/Xid mice (Figure 6B). Analyzing the macrophage popula-
tion after LPS stimulation, we observed a prominent CD11b+F4/
80+ cell population in the peritoneal cavity of BALB/Xid mice,
whereas these cells were absent when mice were treated with
clodronate. In contrast, CD11b+F4/80+ cells were still observed in
the peritoneal cavity of BALB/Xid mice that received B-1 cells
(CFSE+) by adoptive transference, even after clodronate treat-
ment. Quantitative analysis of CFSE+ cells in the CD11b+F4/80+
cell population confirms that B-1 cell-derived phagocytes are an
important component of the macrophage population after LPS
stimulation (Figure 6C). After LPS stimulation, the majority of
macrophages found in the peritoneum of BALB/Xid after
clodronate treatment was CFSE+ (81,74%); hence, they were
derived from B-1 cells. The insert in Figure 6C illustrates the
presence of CFSE+ cells that constitute the macrophage popula-
tion. In agreement with published data [13], CD19 was not
expressed by the B-1 cells after their differentiation into
phagocytes. These data emphasize the differentiation of a B-1
cell into a phagocyte in vivo after LPS stimulation.
Discussion
The concept of the mononuclear phagocyte system (MPS)
proposed by van Furth et al. [1] has been constantly revisited.
According to the MPS concept, all macrophages are derived from
monocytes. However, according to phylogenetic and ontogenetic
points of view, macrophages emerge before the development of
monocytic cells. With regard to ontogeny, primitive and fetal
macrophages first develop in the yolk sac where monocytes are not
detected, and this indicates that in early hematopoiesis, macro-
phages arise bypassing monocyte development [24,25]. In
addition, hematopoietic stem cells have been shown to differen-
tiate without passing through the developmental stages of
monocytic cells. Data here described question the MPS concept,
pointing out that the development and differentiation of
macrophages occurs not in a single cell lineage, but possibly
through multiple pathways.
The differentiation pathway of macrophages via monocytes is
supported by M-CSF and inflammatory signals. It has been
demonstrated that in op/op(2/2) mice, this differentiation
pathway is completely blocked. However, results show that this
blockage does not occur in a number of primitive macrophages or
in immature tissue macrophages suggesting the heterogeneity of
macrophage origin [3,24].
Reports in the literature support the presence of M-CSF-
independent macrophages in op/op(2/2) mice that have differen-
tiated not from monocytes but from early (unidentified) progen-
itors [3,4,5]. M-CSF-independent macrophages are considered
immature macrophages, and it is thought that they are present in
various tissues in the absence of inflammatory signals or that they
rapidly migrate in response to an inflammatory stimulus.
Furthermore, M-CSF-independent macrophages are described as
small round cells characterized by an ultrastructure containing a
low intracellular organelle content, particularly lysosomal granules
[3]. It is interesting to note the similarities between the
morphology of M-CSF-independent macrophages and that
described for B-1 cells [26]. Based on the data reported in this
study, we speculate that the M-CSF-independent macrophages
described in the literature could be derived from B-1 cells.
In this study, we demonstrate that the deficiency of the cfms gene
in op/op(2/2) mice does not influence the peritoneal B-1 cell
population, in the same way as it affects macrophage population.
Furthermore, when compared with normal littermates, B-1 cell
proliferation levels increase with LPS stimulation in op/op(2/2)
mice. Intriguingly, intraperitoneal LPS stimulation resulted in a
significant enlargement in the macrophage population in op/op(2/
2) mice. As discussed above, it is reasonable to suggest two origins
for macrophages, those derived from monocytes and those
‘‘macrophages’’ derived from B-1 cells, which are the predominant
macrophages found in op/op(2/2) mice. This hypothesis is
supported by the Ig gene rearrangement (VH11) found in
‘‘macrophages’’ from op/op(2/2) mice and their normal litter-
mates. Consistent with our previous data, B-1 cell-derived
phagocytes contain the VH11 or VH12 Ig gene rearrangement,
which is typical of B-1 cells [13]. Importantly, the levels of VH11
detected in ‘‘macrophages’’ from op/op(2/2) mice after LPS
stimulation is higher in comparison with the op/op(+/+) levels,
indicating that ‘‘macrophages’’ from op/op(2/2) mice are
predominantly formed by B-1 cell-derived phagocytes. The
transfer of B-1 CFSE+ cells to the peritoneal cavity of BALB/
Xid mice and the presence of CD11b+F4/80+CFSE+ macrophages
support this hypothesis.
Our data also confirm that following an inflammatory stimulus,
the macrophage population in the peritoneal cavity increases not
only due to monocyte migration but also because of proliferation
of resident peritoneal cells. As indicated by Jenkins et al. [27],
pleural macrophages proliferate in situ in response to Th2
products were visualized in agarose gels by ethidium bromide staining. The amount of cDNA input was normalized by analyzing the control GADPH
transcripts. The results are representative of three independent experiments using 8 mice per group per experiment.
doi:10.1371/journal.pone.0034570.g003
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inflammatory signals. The study proposes that macrophage
proliferation in situ is an alternative mechanism of inflammation
that increases the phagocyte population for the performance of
critical functions, such as parasite sequestration or wound repair,
in the absence of potentially damaging cell recruitment. However,
we demonstrated that increase in macrophage population after
Figure 4. Clodronate treatment did not impede the proliferation of resident peritoneal ‘‘macrophages’’ from BALB/c mice treated
with LPS. A) Peritoneal cells were collected from untreated and clodronate-treated mice 3 days after the last clodronate injection. Non-B cells were
selected based on the total peritoneal CD192 cells, and the CD11b+F4/80+ cells were considered macrophages. This CD11b+F4/80+ cell population
was not observed after clodronate treatment. B) Absolute number of peritoneal macrophages (CD192CD11b+F4/80+) from non-clodronate treated
(control group %) or clodronate-treated (&) BALB/c mice after LPS or saline (2) injection. C) Percentage of CFSE+ cells present in the peritoneal
macrophage population (CD192CD11b+F4/80+) in BALB/c mice subjected to different treatments: control (without clodronate+saline injection);
clodronate (clodronate+saline); LPS (without clodronate+LPS injection) and LPS+clodronate (clodronate+LPS). The same group legend was used in
figure 4D and 4E. D) Absolute number of CFSE+ macrophages (CFSE+CD192CD11b+F4/80+) showing high CFSE fluorescence (non-proliferating cells;
CFSE+macrophages) and the decay in CFSE fluorescence (proliferating macrophages). E) Percentage of proliferating macrophages (CFSEdim) detected
in different treated BALB/c mice. F) Absolute number of peritoneal B-1 cells (CD232CD19+CD11b+) in non-clodronate treated (control group %) or
clodronate-treated (&) BALB/c mice after LPS or saline (2) injection. **p,0.01 and ***p,0.001 when the indicated groups are compared. The results
are representative of two or three independent experiments using 5 mice per group per experiment.
doi:10.1371/journal.pone.0034570.g004
Figure 5. LPS induces B-1CDP differentiation and proliferation. A) Analysis of B-1 cell purification and CFSE+ staining. B-1 cells were obtained
from the total peritoneal cells based on the selection of CD19+CD232 cells as described in Figure S1. The first dot plot represents the B-1 cell gate
selected to perform cell sorting. The second dot plot illustrates B-1 cells after cell sorting. Subsequently, these cells were subjected to CFSE staining as
demonstrated in the last dot plot. B) Analysis of expression of CD19 and CD23 by peritoneal lymphocytes confirms the transfer of B-1 cells to BALB/
Xid mice. B-1 cells are almost absent in BALB/Xid and BALB/Xid+LPS mice but are present in significant numbers in BALB/Xid+B-1 and BALB/Xid+B-
1+LPS mice, indicating the efficiency of the B-1 cell transfer. C) Absolute number of B-1 cells (CD19+CD232CD11b+) in the peritoneal cavity of BALB/
Xid (%) and BALB/Xid+B-1 (&) after LPS or saline (2) injection. p,0.001 when the LPS-stimulated group is compared to the non-stimulated group. D)
Analysis of the presence of B-1CDP (CFSE+ cells) in the peritoneal macrophage population (CD192CD11b+F4/80+) from BALB/Xid, BALB/Xid+B-1,
BALB/Xid+LPS and BALB/Xid+B-1+LPS mice. E) Absolute number of peritoneal macrophages (CD192CD11b+F4/80+) from BALB/Xid mice (%) and
BALB/Xid+B-1 mice (&) after LPS or saline (2) injection. * p,0.01 when the indicated group is compared to all groups. The results are representative
of two independent experiments using 5 mice per group per experiment.
doi:10.1371/journal.pone.0034570.g005
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LPS stimulation is a consequence of a proliferation in one of the
resident peritoneal cells, other than monocytes. Moreover, the
transfer of B-1 CFSE+ cells to BALB/Xid mice clearly demon-
strated that LPS treatment leads to B-1 cell proliferation and
differentiation into phagocytes. Based on this data, we question if
monocyte-derived macrophages proliferate in vivo. Furthermore,
we reinforced our hypothesis by considering more than one origin
for peritoneal macrophages. The definitive role of B-1CDPs in the
inflammatory response and their function as macrophages is under
investigation.
The discovery that B-1b cells can be obtained from adherent
mouse peritoneal cell cultures and that these cells spontaneously
differentiate into mononuclear phagocytes that are unrelated to
monocytes introduced a new candidate for the mononuclear
phagocytic system [12,13]. It is important to note that B-1b cells
migrate from the peritoneal cavity to non-specific inflammatory
lesion sites just as monocytes migrate from the bone marrow.
Recent studies in our laboratory support the existence of B-1 cell-
derived phagocytes in vivo [15]. These cells ingest apoptotic bodies
and E. coli bacteria in vivo, although less effectively than
macrophages. Other authors also demonstrated the phagocytic
and microbicidal ability of peritoneal B-1 cells [28]. Consistent with
these data, Borrello and Phipps [29,30] demonstrated that when
splenic B-1a cells were co-cultivated with fibroblasts, they became
phagocytes, which they termed B/macrophages [31]. These authors
proposed that in addition to the monocytic origin of macrophages as
defined by the concept of the mononuclear phagocytic system,
macrophages could also originate from B-1 cells.
Figure 6. B-1CDPs are one of the components of the peritoneal macrophage population after LPS stimulation. A) Absolute number of
peritoneal B-1 cells (CD19+CD232CD11b+) detected in BALB/Xid mice submitted to the specified treatment. ** p,0.01 and ***p,0.001 when the
indicated groups are compared with the non-marked groups. p,0.001 when the two last groups are compared. B) Absolute number of peritoneal
macrophages (CD192CD11b+F4/80+) detected in BALB/Xid mice submitted to the specified treatment. ** p,0.01 and ***p,0.001 when the indicated
groups are compared with the non-marked groups. C) Absolute number of macrophages (CD192CD11b+F4/80+) and the number of B-1CDPs (CFSE+
cells) detected in this population from BALB/Xid mice submitted to the specified treatment. **p,0.01 and ****p,0.001 when the CFSE+ cell number
of the indicated groups are compared with all other groups. The results are representative of two independent experiments using 4 or 5 mice per
group per experiment.
doi:10.1371/journal.pone.0034570.g006
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It has been demonstrated that the pre-B cell line J13
differentiates into CD5-positive ‘‘macrophages’’ after culturing
for 1 month in the presence of GM-CSF [9,10]. Furthermore, the
authors analyzed different mouse strains, including mev/mev, nude,
scid and xid mice, to detect CD5-positive ‘‘macrophages’’ in vivo.
CD5-positive macrophages were observed only in the mev/mev
mice. Importantly, the mev/mev mice are deficient in B and T cells
but have B-1 cells in abundance, which is in contrast to other B-1
cell-deficient strains. In this study, we observed that clodronate
treatment abolished macrophage cells in the peritoneal cavity of
BALB/c and BALB/Xid mice, even after LPS stimulation. The
observation that the ‘‘macrophage’’ population was present in the
peritoneal cavity after clodronate treatment only when B-1 cells
were transferred to BALB/Xid mice supports the hypothesis that
LPS-elicited macrophages originate not only from monocyte-
derived macrophages but also from B-1 cell derived phagocytes.
Additionally, experiments using fetal liver or bone marrow
transplants in scid mice have confirmed that CD5-positive
‘‘macrophages’’ develop from B-1 cells and are detected in milky
spots and the peritoneal cavity [32].
Plytycz and Seljelid [33] proposed that B-1 cells are ‘living
fossils’, and suggested they are primordial cells in the phylogenesis
of the hematopoietic system. Extensive adoptive transfer studies
[34,35,36,37] suggest that the progenitors of B-1a cells reside in
the fetal omentum and fetal liver and are missing in the bone
marrow of adult mice. Furthermore, B-1 cells appear in the para-
aortic splanchnopleura of 9.5 (dpc) embryo mice. A ‘‘primitive’’
macrophage population that is derived from the yolk sac and is not
related to monocytes has been detected in mouse embryos (7 dpc).
Monocytes appear in the embryonic liver on day 11 (pc) when
definitive hematopoiesis occurs [24,38]. Coincidently, B-1 cells
appear in mammals at a similar stage of development, before the
hematopoietic system develops.
The biphenotypic B/macrophage lineage precursor present in
mammals suggests a close evolutionary relationship between B
cells and monocyte-derived macrophages, implying a possible
common phylogenetic predecessor with attributes of both cell
types. Reinforcing this hypothesis is the demonstration by Li and
colleagues [39] that lymphocytes in teleostean fish, a primitive
animal, are biphenotypic.
The data presented here demonstrate a relationship between B-
1CDPs and M-CSF-independent macrophages in op/op(2/2)
mice. The hypothesis that B-1 cell-derived phagocytes are related
to the M-CSF-independent macrophage population is also
supported by the absence of the M-CSF receptor in B-1 cells
[13]. Despite the fact that B-1CDPs acquire MCSF-R after
differentiation in vitro, the absence of the receptor in B-1 cells
suggests that M-CSF do not act as an important factor to induce
differentiation of B-1 cells into phagocytes. However, the role of
M-CSF signaling in B-1 cell differentiation into phagocytes needs
further investigation.
Furthermore, depletion of macrophages by clodronate treat-
ment in a normal mouse strain (BALB/c) confirms the
participation of B-1 cell-derived phagocytes as a component of
the peritoneal macrophage population. Moreover, detection of
CFSE+ macrophages in the peritoneal cavity of BALB/Xid mice
after the transfer of B-1 CFSE+ cells reinforces the hypothesis that
B-1 cells differentiate into phagocytes in vivo after LPS stimulation.
The current knowledge about B-1 cells and their ability to
differentiate into phagocyte, incite a critical visit to MPS concept,
in order to reconsider that vertebrates have at least two
professional mononuclear phagocyte systems: one derived from
monocytes and the other from B-1 cells.
Supporting Information
Figure S1 B-1 cell purification strategy. Peritoneal cells
from BALB/c mice were harvested and stained with fluoro-
chrome-labeled antibodies directed against CD19 and CD23 for
flow cytometric analysis and cell-sorting. (A) Doublet cells were
excluded according to forward scatter profiles (FSC-A6FSC-H).
(B) Considering only single cells, the lymphocyte region was
determined based on SSC-A6FSC-A parameters. (C)
CD19+CD232 cells (B-1 cells) were selected from the lymphocyte
region.
(TIF)
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